You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
17 November 2014
Prosensa Announces 3rd Quarter 2014 Financial Results and Recent Corporate Developments
12 August 2014
Prosensa Announces 2nd Quarter 2014 Financial Results and Recent Corporate Developments
20 May 2014
Prosensa Announces 1st Quarter 2014 Financial Results and Recent Corporate Developments
18 March 2014
Prosensa Announces Full Year 2013 Financial Results and Recent Corporate Developments
13 January 2014
Prosensa Regains Rights to Drisapersen From GSK and Retains Rights to All Other Programs for the Treatment of Duchenne Muscular Dystrophy (DMD)
18 November 2013
Prosensa Announces Third Quarter 2013 Financial Results and Recent Corporate Developments
20 September 2013
GSK and Prosensa Announce Primary Endpoint Not Met in Phase III Study of Drisapersen in Patients With Duchenne Muscular Dystrophy
